DJIA 17,798.49 -14.90 -0.08%
NASDAQ 5,127.53 11.38 0.22%
S&P 500 2,090.11 1.24 0.06%
market minute promo


company name or ticker

Several Biotech Stocks Indicating A Macro Short Strategy

Trade-Ideas: ZIOPHARM Oncology (ZIOP) Is Today's Post-Market Leader Stock

Intrexon Corp is expanding its business

Intrexon Corp is expanding his business

CAR T-Cell Stocks a Better Way to Leverage Biotech Than New 3x ETFs

Will ZIOPHARM Oncology (ZIOP) Stock Decline After Analyst Downgrade?

Barbarian At The Gate: ZIOPHARM Oncology (ZIOP)

Ziopharm Oncology Downgraded By BMO As 'Questions Persist'

What Is Cancer Immunotherapy?

Cancer immunotherapy is rapidly becoming a major new weapon in the fight against this deadly disease. Here is a brief primer on this powerful new technology, as well as a look at where it's likely headed moving forward.

CAR T-Cell Biotechs Look Exciting, But A Word Of Caution On Safety

See More Articles...